Cardiovascular microRNAs: As modulators and diagnostic biomarkers of diabetic heart disease

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Rawal, Shruti ^a   Manning, Patrick ^b   Katare, Rajesh ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Cardiac gene expression; Diabetic heart disease; Diagnostic biomarkers; MicroRNA; Subclinical disease

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1; MICRORNA 126; MICRORNA 132; MICRORNA 133; MICRORNA 208; MICRORNA 499; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGIOGENESIS; CARDIOMYOPATHY; DIABETIC CARDIOMYOPATHY; EARLY DIAGNOSIS; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; MOLECULAR DIAGNOSIS; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; TISSUE REGENERATION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEART DISEASES; HUMANS; MICRORNAS;

EID: 84893792319     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-44     Document Type: Review

References (186)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diab Res Clin Prac 2011, 94:311-321.
2. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 2004, 107:539-557. 10.1042/CS20040057, 15341511.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
4. Kim DH, Saetrom P, Snove O, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 2008, 105:16230-16235. 10.1073/pnas.0808830105, 2571020, 18852463.
5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854. 10.1016/0092-8674(93)90529-Y, 8252621.
6. van Rooij E. The art of microRNA research. Circul Res 2011, 108:219-234.
7. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006, 22:165-173. 10.1016/j.tig.2006.01.003, 16446010.
8. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
9. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934. 10.1126/science.1149460, 18048652.
10. Lee S, Vasudevan S. Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol 2013, 768:97-126. 10.1007/978-1-4614-5107-5_7, 23224967.
11. Jansen JA, Noorman M, Musa H, Stein M, de Jong S, van der Nagel R, Hund TJ, Mohler PJ, Vos MA, van Veen TA, de Bakker JM, Delmar M, van Rijen HV. Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice. Heart rhythm: the official journal of the Heart Rhythm Society 2012, 9(4):600-607. 10.1016/j.hrthm.2011.11.025, 3336370, 22100711.
12. Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G, Oikawa A, Cesselli D, Beltrami AP, Giacca M, Emanueli C, Madeddu P. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circulation research 2011, 108(10):1238-1251. 10.1161/CIRCRESAHA.110.239111, 21474815.
13. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci U S A 2007, 104:20844-20849. 10.1073/pnas.0710558105, 2409229, 18093911.
14. Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drug Ther 2011, 25:171-182.
15. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220. 10.1038/nature03817, 15951802.
16. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 2006, 103:8721-8726. 10.1073/pnas.0602831103, 1482645, 16731620.
17. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007, 100:416-424. 10.1161/01.RES.0000257913.42552.23, 17234972.
18. Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, Pu WT. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Molecular and cellular biology 2009, 29(8):2193-2204. 10.1128/MCB.01222-08, 2663304, 19188439.
19. Yildirim SS, Akman D, Catalucci D, Turan B. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: Junctin as a target protein of miR-1. Cell Biochem Biophys 2013, 67:1397-1408. 10.1007/s12013-013-9672-y, 23723006.
20. Belevych AE, Sansom SE, Terentyeva R, Ho HT, Nishijima Y, Martin MM, Jindal HK, Rochira JA, Kunitomo Y, Abdellatif M, Carnes CA, Elton TS, Gyorke S, Terentyev D. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PloS one 2011, 6(12):e28324. 10.1371/journal.pone.0028324, 3232211, 22163007.
21. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature medicine 2007, 13(4):486-491. 10.1038/nm1569, 17401374.
22. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129:303-317. 10.1016/j.cell.2007.03.030, 17397913.
23. Condorelli G, Latronico MV, Dorn GW. microRNAs in heart disease: putative novel therapeutic targets?. Eur Heart J 2010, 31:649-658. 10.1093/eurheartj/ehp573, 2838683, 20118173.
24. Zhang Y, Sun L, Liang H, Li X, Cai R, Wang L, Du W, Zhang R, Li J, Wang Z, Ma N, Wang X, Du Z, Yang B, Gao X, Shan H. Overexpression of microRNA-1 Causes Atrioventricular Block in Rodents. International journal of biological sciences 2013, 9(5):455-462. 10.7150/ijbs.4630, 3654494, 23678295.
25. Huang ZP, Neppl RL, Wang DZ. MicroRNAs in cardiac remodeling and disease. J Cardiovasc Transl Res 2010, 3:212-218. 10.1007/s12265-010-9165-y, 20560042.
26. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circulation research 2011, 109(8):880-893. 10.1161/CIRCRESAHA.111.240150, 21852550.
27. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Yang B, Wang Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007, 282:12363-12367. 10.1074/jbc.C700015200, 17344217.
28. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes & Dev 2008, 22:3242-3254. 10.1101/gad.1738708, 2600761, 19015276.
29. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circulation research 2009, 104(2):170-178. 10.1161/CIRCRESAHA.108.182535, 19096030.
30. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science signaling 2009, 2(100):ra81.
31. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation research 2010, 107(6):810-817. 10.1161/CIRCRESAHA.110.226357, 20651284.
32. Meister J, Schmidt MH. miR-126 and miR-126*: new players in cancer. Scientific World Journal 2010, 10:2090-2100.
33. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, Koeppel TA, Zernecke A, Weber C. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thrombosis and haemostasis 2012, 107:619-625. 10.1160/TH11-09-0607, 22370758.
34. Staszel T, Zapala B, Polus A, Sadakierska-Chudy A, Kiec-Wilk B, Stepien E, Wybranska I, Chojnacka M, Dembinska-Kiec A. Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 2011, 121:361-366.
35. Sessa R, Seano G, di Blasio L, Gagliardi PA, Isella C, Medico E, Cotelli F, Bussolino F, Primo L. The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85beta. Biochimica Et Biophysica Acta 2012, 1823:1925-1935. 10.1016/j.bbamcr.2012.07.011, 22867989.
36. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008, 15:261-271. 10.1016/j.devcel.2008.07.002, 2685763, 18694565.
37. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax PH, Rabelink TJ, van Zonneveld AJ. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of cellular and molecular medicine 2009, 13(8A):1577-1585. 10.1111/j.1582-4934.2008.00613.x, 19120690.
38. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S, Mayr M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. Journal of the American College of Cardiology 2012, 60(4):290-299. 10.1016/j.jacc.2012.03.056, 22813605.
39. Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ. Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arteriosclerosis, Thrombosis Vascular Biol 1990-1997, 2010:30(10).
40. Sun YQ, Zhang F, Bai YF, Guo LL. miR-126 modulates the expression of epidermal growth factor-like domain 7 in human umbilical vein endothelial cells in vitro. Nan fang yi ke da xue xue bao 2010, 30:767-770.
41. Babiarz JE, Ravon M, Sridhar S, Ravindran P, Swanson B, Bitter H, Weiser T, Chiao E, Certa U, Kolaja KL. Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling. Stem Cells Dev 2012, 21:1956-1965. 10.1089/scd.2011.0357, 22050602.
42. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579. 10.1126/science.1139089, 17379774.
43. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of clinical investigation 2009, 119(9):2772-2786. 10.1172/JCI36154, 2735902, 19726871.
44. Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Cardiac Failure 2010, 16:404-410.
45. Li X, Wang J, Jia Z, Cui Q, Zhang C, Wang W, Chen P, Ma K, Zhou C. MiR-499 Regulates Cell Proliferation and Apoptosis during Late-Stage Cardiac Differentiation via Sox6 and Cyclin D1. PloS One 2013, 8:e74504. 10.1371/journal.pone.0074504, 3770584, 24040263.
46. Shieh JT, Huang Y, Gilmore J, Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PloS one 2011, 6:e19481. 10.1371/journal.pone.0019481, 3090396, 21573063.
47. Ling TY, Wang XL, Chai Q, Lau TW, Koestler CM, Park SJ, Daly RC, Greason KL, Jen J, Wu LQ, Shen WF, Shen WK, Cha YM, Lee HC. Regulation of the SK3 channel by microRNA-499-Potential role in atrial fibrillation. Heart rhythm: the official journal of the Heart Rhythm Society 2013, 10:1001-1009. 10.1016/j.hrthm.2013.03.005, 23499625.
48. Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, Li YR, Li PF. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011, 17:71-78. 10.1038/nm.2282, 21186368.
49. Matkovich SJ, Hu Y, Eschenbacher WH, Dorn LE, Dorn GW. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res 2012, 111:521-531. 10.1161/CIRCRESAHA.112.265736, 3429338, 22752967.
50. Wang N, Yang C, Xie F, Sun L, Su X, Wang Y, Wei R, Zhang R, Li X, Yang B, Ai J. Gadd45alpha: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction. PloS one 2012, 7(12):e49077. 10.1371/journal.pone.0049077, 3515561, 23227140.
51. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010, 30:859-868. 10.1161/ATVBAHA.109.197434, 20081117.
52. Yeung F, Chung E, Guess MG, Bell ML, Leinwand LA. Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res 2012, 40:7303-7318. 10.1093/nar/gks466, 3424578, 22638570.
53. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH, Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 2005, 102:16426-16431. 10.1073/pnas.0508448102, 1283476, 16260724.
54. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature medicine 2010, 16(8):909-914. 10.1038/nm.2186, 3094020, 20676106.
55. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami AP, Angelini G, Emanueli C, Madeddu P. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circulation research 2011, 109(8):894-906. 10.1161/CIRCRESAHA.111.251546, 3623091, 21868695.
56. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nature communications 2012, 3:1078. 3657998, 23011132.
57. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat cell Biol 2007, 9:654-659. 10.1038/ncb1596, 17486113.
58. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C, Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PloS one 2010, 5:e11803. 10.1371/journal.pone.0011803, 2910725, 20668554.
59. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(12):5003-5008. 10.1073/pnas.1019055108, 3064324, 21383194.
60. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433. 10.1038/ncb2210, 3074610, 21423178.
61. Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012, 303:H1085-H1095. 10.1152/ajpheart.00191.2012, 22942181.
62. Asmal AC, Leary WP, Thandroyen F. Diabetic heart disease. S Afr Med J 1980, 57:788-790.
63. Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, Huisman MV, Jukema JW. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 2008, 51:1581-1593. 10.1007/s00125-008-1062-4, 2516193, 18607561.
64. Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM, Bers DM. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013, 502(7471):372-376. 10.1038/nature12537, 24077098.
65. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996, 77:1017-1020. 10.1016/S0002-9149(97)89163-1, 8644628.
66. Nicolino A, Longobardi G, Furgi G, Rossi M, Zoccolillo N, Ferrara N, Rengo F. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995, 8:382-389. 10.1016/0895-7061(95)00022-H, 7619351.
67. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diab care 2001, 24:5-10.
68. Konduracka E, Cieslik G, Galicka-Latala D, Rostoff P, Pietrucha A, Latacz P, Gajos G, Malecki MT, Nessler J. Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study. Acta Diabetologica 2013, 50:597-606. 10.1007/s00592-013-0455-0, 3778905, 23358920.
69. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diab Care 2004, 27:1879-1884.
70. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038. 10.1001/jama.1979.03290450033020, 430798.
71. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34. 10.1016/0002-9149(74)90089-7, 4835750.
72. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diab Care 2001, 24:1614-1619.
73. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 2003, 34:89-99. 10.1016/S0188-4409(03)00004-3, 12700003.
74. Liu JW, Liu D, Cui KZ, Xu Y, Li YB, Sun YM, Su Y. Recent advances in understanding the biochemical and molecular mechanism of diabetic cardiomyopathy. Biochem Biophys Res Commun 2012, 427:441-443. 10.1016/j.bbrc.2012.09.058, 22995317.
75. Chen ZC, Cheng YZ, Chen LJ, Cheng KC, Li Y, Cheng J. Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats. Cardiovasc Diabetol 2012, 11:8. 10.1186/1475-2840-11-8, 3274424, 22257425.
76. Katare R, Caporali A, Emanueli C, Madeddu P. Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response. J Mol Cell Cardiol 2010, 49:625-638. 10.1016/j.yjmcc.2010.05.014, 3017952, 20542491.
77. Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P. Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 2010, 3:294-305. 10.1161/CIRCHEARTFAILURE.109.903450, 2865995, 20107192.
78. Diao X, Shen E, Wang X, Hu B. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice. Mol Med Rep 2011, 4:633-640.
79. de Cillis E, Leonardini A, Laviola L, Giorgino F, Tupputi Schinosa Lde L, Bortone AS. Different gene expression in human heart tissue and progenitor cells from control and diabetic subjects: relevance to the pathogenesis of human diabetic cardiomyopathy. Surg Technol Int 2010, 19:165-174.
80. Oakley RH, Ren R, Cruz-Topete D, Bird GS, Myers PH, Boyle MC, Schneider MD, Willis MS, Cidlowski JA. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc Natl Acad Sci U S A 2013, 110:17035-17040. 10.1073/pnas.1302546110, 24082121.
81. Karakikes I, Kim M, Hadri L, Sakata S, Sun Y, Zhang W, Chemaly ER, Hajjar RJ, Lebeche D. Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a. PloS one 2009, 4:e6474. 10.1371/journal.pone.0006474, 2714457, 19649297.
82. Sárközy M, Zvara A, Gyemant N, Fekete V, Kocsis GF, Pipis J, Szucs G, Csonka C, Puskas LG, Ferdinandy P, Csont T. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats. Cardiovascular diabetology 2013, 12:16. 10.1186/1475-2840-12-16, 3599923, 23320804.
83. Kolodziejczyk SM, Wang L, Balazsi K, DeRepentigny Y, Kothary R, Megeney LA. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 1999, 9:1203-1206. 10.1016/S0960-9822(00)80027-5, 10531040.
84. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233. 10.1038/ng1725, 2538576, 16380711.
85. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
86. Li Y, Song YH, Li F, Yang T, Lu YW, Geng YJ. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun 2009, 381:81-83. 10.1016/j.bbrc.2009.02.013, 2670889, 19351599.
87. Zhao H, Guan J, Lee HM, Sui Y, He L, Siu JJ, Tse PP, Tong PC, Lai FM, Chan JC. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas 2010, 39:843-846. 10.1097/MPA.0b013e3181d12613, 20467341.
88. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nature medicine 2007, 13(5):613-618. 10.1038/nm1582, 17468766.
89. Cardin S, Guasch E, Luo X, Naud P, Le Quang K, Shi Y, Tardif JC, Comtois P, Nattel S. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol 2012, 5:1027-1035. 10.1161/CIRCEP.112.973214, 22923342.
90. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739.
91. Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009, 73:1492-1497. 10.1253/circj.CJ-08-1032, 19521018.
92. Kolwicz SC, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res 2011, 90:194-201. 10.1093/cvr/cvr071, 3078804, 21502371.
93. Young LH, Russell RR, Yin R, Caplan MJ, Ren J, Bergeron R, Shulman GI, Sinusas AJ. Regulation of myocardial glucose uptake and transport during ischemia and energetic stress. Am J Cardiol 1999, 83:25H-30H.
94. Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M, Kuwabara Y, Takanabe R, Hasegawa K, Kita T, Kimura T. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochemical and biophysical research communications 2009, 389(2):315-320. 10.1016/j.bbrc.2009.08.136, 19720047.
95. Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 2010, 26:40-49. 10.1002/dmrr.1054, 20013939.
96. Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX, Lin SG, Li Y. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem Biophys Res Commun 2008, 376:548-552. 10.1016/j.bbrc.2008.09.025, 18801338.
97. Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL, Fu YH, Liu XY, Li YX, Zhang YY, Lin SG, Yu XY. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS letters 2010, 584(16):3592-3600. 10.1016/j.febslet.2010.07.027, 20655308.
98. Pan Z, Sun X, Ren J, Li X, Gao X, Lu C, Zhang Y, Sun H, Wang Y, Wang H, Wang J, Xie L, Lu Y, Yang B. miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PloS one 2012, 7(11):e50515. 10.1371/journal.pone.0050515, 3511560, 23226300.
99. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 1999, 31:1937-1948. 10.1006/jmcc.1999.1026, 10525430.
100. Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001, 103:1787-1792. 10.1161/01.CIR.103.13.1787, 11282911.
101. Shan H, Zhang Y, Cai B, Chen X, Fan Y, Yang L, Liang H, Song X, Xu C, Lu Y, Yang B, Du Z. Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling. International journal of cardiology 2013, 167:2798-2805. 10.1016/j.ijcard.2012.07.009, 22889704.
102. Sun Y, Hu D. The link between diabetes and atrial fibrillation: cause or correlation?. J Cardiovasc Dis Res 2010, 1:10-11. 3004163, 21188083.
103. Hofmann F, Fabritz L, Stieber J, Schmitt J, Kirchhof P, Ludwig A, Herrmann S. Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. Cardiovasc Res 2012, 95:317-326. 10.1093/cvr/cvs184, 22652004.
104. Hofmann PA, Menon V, Gannaway KF. Effects of diabetes on isometric tension as a function of [Ca2+] and pH in rat skinned cardiac myocytes. Am J Physiol 1995, 269:H1656-H1663.
105. Yeih DF, Yeh HI, Hsin HT, Lin LY, Chiang FT, Tseng CD, Chu SH, Tseng YZ. Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: role of myosin heavy chain isozyme. Am J Physiol 2009, 297:H1411-H1420.
106. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009, 17:662-673. 10.1016/j.devcel.2009.10.013, 2796371, 19922871.
107. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009, 119:1263-1271. 10.1161/CIRCULATIONAHA.108.813576, 2749457, 19237659.
108. Tuteja D, Xu D, Timofeyev V, Lu L, Sharma D, Zhang Z, Xu Y, Nie L, Vazquez AE, Young JN, Glatter KA, Chiamvimonvat N. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. American journal of physiology Heart and circulatory physiology 2005, 289(6):H2714-H2723. 10.1152/ajpheart.00534.2005, 16055520.
109. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, Sinner MF, de Bakker PI, Mueller M, Lubitz SA, Fox E, Darbar D, Smith NL, Smith JD, Schnabel RB, Soliman EZ, Rice KM, Van Wagoner DR, Beckmann BM, van Noord C, Wang K, Ehret GB, Rotter JI, Hazen SL, Steinbeck G, Smith AV, Launer LJ, Harris TB, Makino S, Nelis M, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nature genetics 2010, 42(3):240-244. 10.1038/ng.537, 2871387, 20173747.
110. Tanaka A, Youle RJ. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol Cell 2008, 29:409-410. 10.1016/j.molcel.2008.02.005, 18313377.
111. Tan WQ, Wang JX, Lin ZQ, Li YR, Lin Y, Li PF. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation 2008, 118:2268-2276. 10.1161/CIRCULATIONAHA.107.750869, 19001025.
112. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001, 1:515-525. 10.1016/S1534-5807(01)00055-7, 11703942.
113. Chavali V, Tyagi SC, Mishra PK. Differential Expression of Dicer, miRNAs, and Inflammatory Markers in Diabetic Ins2+/- Akita Hearts. Cell Biochem Biophys 2014, 68:25-35. 10.1007/s12013-013-9679-4, 23797610.
114. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010, 464:1196-1200. 10.1038/nature08889, 2914488, 20364122.
115. Jakob P, Landmesser U. Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 2012, 93:614-622. 10.1093/cvr/cvr311, 22135162.
116. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006, 48:180-186. 10.1161/01.HYP.0000231507.00962.b5, 16801490.
117. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284. 10.1016/j.devcel.2008.07.008, 2604134, 18694566.
118. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N. Assessment of plasma miRNAs in congestive heart failure. Circ J 2011, 75:336-340. 10.1253/circj.CJ-10-0457, 21157109.
119. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circulation research 2010, 107(5):677-684. 10.1161/CIRCRESAHA.109.215566, 20595655.
120. Anand S, Cheresh DA. MicroRNA-mediated regulation of the angiogenic switch. Curr Opin Hematol 2011, 18:171-176. 10.1097/MOH.0b013e328345a180, 3159578, 21423013.
121. Shen E, Diao X, Wang X, Chen R, Hu B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol 2011, 179:639-650. 10.1016/j.ajpath.2011.04.034, 3157194, 21704010.
122. Lu H, Buchan RJ, Cook SA. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 2010, 86:410-420. 10.1093/cvr/cvq010, 20080987.
123. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L, Martelli F. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 2012, 61:1633-1641. 10.2337/db11-0952, 3357263, 22427379.
124. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260. 10.1073/pnas.0608791103, 1838739, 17108080.
125. Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ, Hoeben RC, Akhyari P, Al-Hasani H, Ruige JB, Ouwens DM. Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143. Cardiovascular research 2013, 100(2):201-210. 10.1093/cvr/cvt173, 23812417.
126. Blumensatt M, Wronkowitz N, Wiza C, Cramer A, Mueller H, Rabelink MJ, Hoeben RC, Eckel J, Sell H, Ouwens DM. Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143. Biochimica Et Biophysica Acta 2014, 1842:275-283. 10.1016/j.bbadis.2013.12.001, 24333576.
127. Panguluri SK, Tur J, Chapalamadugu KC, Katnik C, Cuevas J, Tipparaju SM. MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators. PloS one 2013, 8:e60545. 10.1371/journal.pone.0060545, 3616003, 23573265.
128. Baseler WA, Thapa D, Jagannathan R, Dabkowski ER, Croston TL, Hollander JM. miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. Am J Physiol Cell Physiol 2012, 303:C1244-C1251. 10.1152/ajpcell.00137.2012, 3532490, 23034391.
129. Nishi Y, Fujimoto S, Sasaki M, Mukai E, Sato H, Sato Y, Tahara Y, Nakamura Y, Inagaki N. Role of mitochondrial phosphate carrier in metabolism-secretion coupling in rat insulinoma cell line INS-1. Biochem J 2011, 435:421-430. 10.1042/BJ20101708, 21265734.
130. Kramer R. Structural and functional aspects of the phosphate carrier from mitochondria. Kidney Intern 1996, 49:947-952.
131. Monji A, Mitsui T, Bando YK, Aoyama M, Shigeta T, Murohara T. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes. Am J Physiol Heart Circ Physiol 2013, 305:H295-H304. 10.1152/ajpheart.00990.2012, 23709595.
132. Fu Y, Zhang Y, Wang Z, Wang L, Wei X, Zhang B, Wen Z, Fang H, Pang Q, Yi F. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am J Nephrol 2010, 32:581-589. 10.1159/000322105, 21071935.
133. Varga ZV, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N, Zvara A, Puskas LG, Razga Z, Tiszlavicz L, Bencsik P, Gorbe A, Csonka C, Ferdinandy P, Csont T. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. Journal of molecular and cellular cardiology 2013, 62:111-121.
134. Gao S, Yuan K, Shah A, Kim JS, Park WH, Kim SH. Suppression of high pacing-induced ANP secretion by antioxidants in isolated rat atria. Peptides 2011, 32:2467-2473. 10.1016/j.peptides.2011.10.022, 22063193.
135. Setyowati Karolina D, Sepramaniam S, Tan HZ, Armugam A, Jeyaseelan K. miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA Biol 2013, 10:1365-1378. 10.4161/rna.25557, 24084692.
136. Dirkx E, Gladka MM, Philippen LE, Armand AS, Kinet V, Leptidis S, El Azzouzi H, Salic K, Bourajjaj M, da Silva GJ, Olieslagers S, van der Nagel R, de Weger R, Bitsch N, Kisters N, Seyen S, Morikawa Y, Chanoine C, Heymans S, Volders PG, Thum T, Dimmeler S, Cserjesi P, Eschenhagen T, da Costa Martins PA, De Windt LJ. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nature cell biology 2013, 15(11):1282-1293. 10.1038/ncb2866, 24161931.
137. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116(3):258-267. 10.1161/CIRCULATIONAHA.107.687947, 17606841.
138. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012, 37:460-465. 10.1016/j.tibs.2012.08.003, 22944280.
139. Matkovich SJ, Hu Y, Dorn GW. Regulation of cardiac microRNAs by cardiac microRNAs. Circ Res 2013, 113:62-71. 10.1161/CIRCRESAHA.113.300975, 23625950.
140. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012, 110:1465-1473. 10.1161/CIRCRESAHA.112.269035, 3380624, 22539765.
141. Caporali A, Emanueli C. MicroRNAs in Postischemic Vascular Repair. Cardiol Res Pract 2012, 2012:486702. 3312206, 22482069.
142. Chen JJ, Zhou SH. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiology J 2011, 18:675-681.
143. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492:376-381. 10.1038/nature11739, 23222520.
144. Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circulation Cardiovascular genetics 2010, 3(5):426-435. 10.1161/CIRCGENETICS.109.934281, 3057038, 20733065.
145. Zhang LL, Liu JJ, Liu F, Liu WH, Wang YS, Zhu B, Yu B. MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun 2012, 420:875-881. 10.1016/j.bbrc.2012.03.092, 22465011.
146. Dorn GW, Matkovich SJ, Eschenbacher WH, Zhang Y. A human 3' miR-499 mutation alters cardiac mRNA targeting and function. Circ Res 2012, 110:958-967. 10.1161/CIRCRESAHA.111.260752, 3320730, 22374132.
147. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ, Taegtmeyer H. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 2000, 32:985-996. 10.1006/jmcc.2000.1139, 10888252.
148. Di Bonito P, Moio N, Cavuto L, Covino G, Murena E, Scilla C, Turco S, Capaldo B, Sibilio G. Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diab Med 2005, 22:1720-1725.
149. Perrone-Filardi P, Achenbach S, Mohlenkamp S, Reiner Z, Sambuceti G, Schuijf JD, Van der Wall E, Kaufmann PA, Knuuti J, Schroeder S, Zellweger MJ. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. European heart journal 2011, 32(16):1986-1993. 1993a, 1993b, 10.1093/eurheartj/ehq235, 20630895.
150. Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH. Screening for heart disease in diabetic subjects. Am Heart J 2005, 149:349-354. 10.1016/j.ahj.2004.06.021, 15846276.
151. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003, 41:611-617. 10.1016/S0735-1097(02)02869-3, 12598073.
152. Olivieri F, Galeazzi R, Giavarina D, Testa R, Abbatecola AM, Ceka A, Tamburrini P, Busco F, Lazzarini R, Monti D, Franceschi C, Procopio AD, Antonicelli R. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mechanisms of ageing and development 2012, 133(5):300-305. 10.1016/j.mad.2012.03.005, 22446505.
153. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010, 56:941-943. 10.1373/clinchem.2010.143958, 20360122.
154. Baker JO, Reinhold J, Redwood S, Marber MS. Troponins: redefining their limits. Heart 2011, 97:447-452. 10.1136/hrt.2010.205617, 21193685.
155. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Frohlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Munzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. The New England journal of medicine 2009, 361(9):868-877. 10.1056/NEJMoa0903515, 19710485.
156. Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med 2010, 8:34. 10.1186/1741-7015-8-34, 2898678, 20529285.
157. Szymanski FM, Karpinski G, Platek AE, Majstrak F, Hrynkiewicz-Szymanska A, Kotkowski M, Puchalski B, Filipiak KJ, Opolski G. Clinical characteristics, etiology and occurrence of type 2 acute myocardial infarction. Kardiologia polska in press.
158. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007, 167:276-281. 10.1001/archinte.167.3.276, 17296884.
159. Neil HA, Thompson AV, Thorogood M, Fowler GH, Mann JI. Diabetes in the elderly: the Oxford Community Diabetes Study. Diab Med 1989, 6:608-613.
160. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628-1637. 10.1016/S0735-1097(00)00582-9, 10807470.
161. Jaffe AS. Elevations in cardiac troponin measurements: false false-positives: the real truth. Cardiovasc Toxicol 2001, 1:87-92. 10.1385/CT:1:2:087, 12213978.
162. Ambhore A, Teo SG, Poh KK. Diabetes mellitus and heart disease. Singapore Med J 2013, 54:370-375. quiz 376, 10.11622/smedj.2013136, 23900465.
163. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta diabetologica 2011, 48(1):61-69. 10.1007/s00592-010-0226-0, 20857148.
164. Pescador N, Perez-Barba M, Ibarra JM, Corbaton A, Martinez-Larrad MT, Serrano-Rios M. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PloS one 2013, 8:e77251. 10.1371/journal.pone.0077251, 3817315, 24204780.
165. Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, Lim SC, Sum CF, Jeyaseelan K. Circulating miRNA profiles in patients with metabolic syndrome. J of Clin Endocrinol and Metab 2012, 97:E2271-2276.
166. Sebastiani G, Nigi L, Spagnuolo I, Morganti E, Fondelli C, Dotta F. MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications. J Biomed Sci Eng 2013, 6:58-64.
167. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Experimental diabetes research 2012, 2012:896362. 3398606, 22829805.
168. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(30):10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
169. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research 2008, 18(10):997-1006. 10.1038/cr.2008.282, 18766170.
170. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368:29-36. 10.1016/S0140-6736(06)68967-8, 16815377.
171. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666. 10.1093/eurheartj/ehq013, 20159880.
172. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clini Chem 2009, 55:1944-1949.
173. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010, 3:499-506. 10.1161/CIRCGENETICS.110.957415, 20921333.
174. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European heart journal 2010, 31(22):2765-2773. 10.1093/eurheartj/ehq167, 2980809, 20534597.
175. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation Cardiovascular genetics 2011, 4(4):446-454. 10.1161/CIRCGENETICS.110.958975, 21642241.
176. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010, 56:1183-1185. 10.1373/clinchem.2010.144121, 20395621.
177. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and biophysical research communications 2010, 391(1):73-77. 10.1016/j.bbrc.2009.11.005, 19896465.
178. Zhang R, Niu H, Ban T, Xu L, Li Y, Wang N, Sun L, Ai J, Yang B. Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction. Int J Cardiol 2013, 166:259-260. 10.1016/j.ijcard.2012.09.108, 23079087.
179. Wang R, Li N, Zhang Y, Ran Y, Pu J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 2011, 50:1789-1795. 10.2169/internalmedicine.50.5129, 21881276.
180. Gidlof O, Andersson P, van der Pals J, Gotberg M, Erlinge D. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 2011, 118:217-226. 10.1159/000328869, 21701171.
181. Gidlof O, Smith JG, Miyazu K, Gilje P, Spencer A, Blomquist S, Erlinge D. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Disord 2013, 13:12. 10.1186/1471-2261-13-12, 3598930, 23448306.
182. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, Chen C, Wang DW. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012, 8:811-818. 3372885, 22719221.
183. Friesinger GC, Smith RF. Old age, left bundle branch block and acute myocardial infarction: a vexing and lethal combination. J Am Coll Cardiol 2000, 36:713-716. 10.1016/S0735-1097(00)00801-9, 10987589.
184. Challa PK, Smith KM, Conti CR. Initial presenting electrocardiogram as determinant for hospital admission in patients presenting to the emergency department with chest pain: a pilot investigation. Clin Cardiol 2007, 30:558-561. 10.1002/clc.20141, 18000960.
185. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001, 38:478-485. 10.1016/S0735-1097(01)01388-2, 11499741.
186. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La Sala L, Galeazzi R, Recchioni R, Testa R, Pompilio G, Capogrossi MC, Procopio AD. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International journal of cardiology 2013, 167:531-536. 10.1016/j.ijcard.2012.01.075, 22330002.